$ORGN
Origin Materials, Inc. Stock $orgn

$orgn Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000180245721000008 Filed on November 12, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue			$140.3K
YoY Change
Gross Profit			-$140.3K
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.055M	$5.043M	$740.0K
YoY Change	-10.29%	581.49%
% of Gross Profit
Research & Development	$3.519M	$1.957M	$1.190M
YoY Change	323.98%	64.45%
% of Gross Profit
Depreciation & Amortization	$182.0K	$100.0K	$100.0K
YoY Change	7.06%	0.0%
% of Gross Profit
Operating Expenses	$7.755M	$7.126M	$2.029M
YoY Change		251.21%
Operating Profit			-$140.3K
YoY Change
Interest Expense	$1.514M	$0.00	$54.00K
YoY Change	-106.61%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$11.48M	$35.02M	-$1.077M
YoY Change	-168.32%	-3351.53%
Pretax Income	$5.237M	$27.89M	-$62.19K
YoY Change	-120.3%	-44951.26%
Income Tax
% Of Pretax Income
Net Earnings	$5.237M	$27.89M	-$3.106M
YoY Change	-120.3%	-998.04%
Net Earnings / Revenue
Basic Earnings Per Share		$0.20	-$0.05
Diluted Earnings Per Share	$37.06K	$0.20	-$0.05
COMMON SHARES
Basic Shares Outstanding	141.3M shares	136.7M shares	62.55M shares
Diluted Shares Outstanding		141.2M shares	62.55M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$444.1M	$459.3M	$1.262M
YoY Change	33826.28%	36302.89%
Cash & Equivalents	$46.64M	$459.3M	$1.262M
Short-Term Investments	$397.5M
Other Short-Term Assets	$4.466M	$4.352M	$290.3K
YoY Change	1922.0%	1399.29%
Inventory
Prepaid Expenses			$290.3K
Receivables
Other Receivables	$2.612M	$262.0K
Total Short-Term Assets	$451.2M	$463.9M	$1.552M
YoY Change	22402.39%	29792.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.19M	$49.95M
YoY Change	26.78%
Goodwill
YoY Change
Intangibles	$215.0K	$225.0K
YoY Change	-16.67%
Long-Term Investments			$724.6M
YoY Change
Other Assets	$62.00K
YoY Change	0.0%
Total Long-Term Assets	$59.24M	$50.18M	$724.6M
YoY Change	30.42%	-93.08%
TOTAL ASSETS
Total Short-Term Assets	$451.2M	$463.9M	$1.552M
Total Long-Term Assets	$59.24M	$50.18M	$724.6M
Total Assets	$510.4M	$514.1M	$726.1M
YoY Change	976.17%	-29.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.451M	$1.783M
YoY Change	-9.22%
Accrued Expenses	$973.0K	$1.135M	$15.61K
YoY Change	64.08%	7170.98%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.187M	$2.918M	$25.37M
YoY Change	-46.07%	-88.5%
LONG-TERM LIABILITIES
Long-Term Debt	$5.189M	$5.189M	$0.00
YoY Change
Other Long-Term Liabilities	$2.946M	$2.984M
YoY Change	17.84%
Total Long-Term Liabilities	$2.946M	$2.984M	$0.00
YoY Change	17.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.187M	$2.918M	$25.37M
Total Long-Term Liabilities	$2.946M	$2.984M	$0.00
Total Liabilities	$206.9M	$215.1M	$25.37M
YoY Change	337.38%	747.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$56.80M	-$62.04M	-$71.25K
YoY Change	-42.56%	86961.78%
Common Stock	$16.00K	$13.00K
YoY Change	166.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$303.5M	$299.0M	$20.30M
YoY Change
Total Liabilities & Shareholders Equity	$510.4M	$514.1M	$726.1M
YoY Change	976.17%	-29.2%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	$5.237M	$27.89M	-$3.106M
YoY Change	-120.3%	-998.04%
Depreciation, Depletion And Amortization	$182.0K	$100.0K	$100.0K
YoY Change	7.06%	0.0%
Cash From Operating Activities	-$6.427M	-$8.941M	-$424.0K
YoY Change	4548.15%	2008.73%
INVESTING ACTIVITIES
Capital Expenditures	-$7.356M	-$2.410M	$1.400M
YoY Change	-1231.69%	-272.14%
Acquisitions
YoY Change
Other Investing Activities	-$399.2M		-$724.5M
YoY Change
Cash From Investing Activities	-$406.5M	-$2.410M	-$724.5M
YoY Change		-99.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	274.0K	115.0K	726.2M
YoY Change		-99.98%
NET CHANGE
Cash From Operating Activities	-6.427M	-8.941M	-424.0K
Cash From Investing Activities	-406.5M	-2.410M	-724.5M
Cash From Financing Activities	274.0K	115.0K	726.2M
Net Change In Cash	-412.7M	-11.24M	1.262M
YoY Change	298358.09%	-990.56%
FREE CASH FLOW
Cash From Operating Activities	-$6.427M	-$8.941M	-$424.0K
Capital Expenditures	-$7.356M	-$2.410M	$1.400M
Free Cash Flow	$929.0K	-$6.531M	-$1.824M
YoY Change	-217.85%	258.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001802457
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Entity Registrant Name EntityRegistrantName	ORIGIN MATERIALS, INC.
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39378
	dei	City Area Code CityAreaCode	916
	dei	Local Phone Number LocalPhoneNumber	231-9329
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1388928
	dei	Entity Address Address Line1 EntityAddressAddressLine1	930 Riverside Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 10
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Sacramento,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95605
	dei	Trading Symbol TradingSymbol	ORGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	141254685	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	459288000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1309000	USD
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	565000	USD
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	262000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	48000	USD
CY2021Q3	us-gaap	Grants Receivable Current GrantsReceivableCurrent	16000	USD
CY2020Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	0	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3862000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	144000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	463918000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2066000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49951000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45104000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	225000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	258000	USD
CY2021Q3	us-gaap	Assets Assets	514094000	USD
CY2020Q4	us-gaap	Assets Assets	47428000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1783000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2700000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1135000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	593000	USD
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1239000	USD
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3232000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2918000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7764000	USD
CY2021Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	USD
CY2020Q4	us-gaap	Liabilities Liabilities	47306000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	906000	USD
CY2021Q3	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	136199000	USD
CY2020Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	0	USD
CY2021Q3	orgn	Research And Development Program Liability Noncurrent ResearchAndDevelopmentProgramLiabilityNoncurrent	6485000	USD
CY2020Q4	orgn	Research And Development Program Liability Noncurrent ResearchAndDevelopmentProgramLiabilityNoncurrent	6197000	USD
CY2021Q3	orgn	Redeemable Convertible Preferred Stock Warrants Noncurrent RedeemableConvertiblePreferredStockWarrantsNoncurrent	0	USD
CY2020Q4	orgn	Redeemable Convertible Preferred Stock Warrants Noncurrent RedeemableConvertiblePreferredStockWarrantsNoncurrent	19233000	USD
CY2021Q3	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	55698000	USD
CY2020Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	0	USD
CY2021Q3	orgn	Stockholder Note Liabilities Noncurrent StockholderNoteLiabilitiesNoncurrent	5189000	USD
CY2020Q4	orgn	Stockholder Note Liabilities Noncurrent StockholderNoteLiabilitiesNoncurrent	5189000	USD
CY2021Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5669000	USD
CY2020Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5517000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2984000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2500000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	215142000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47428000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	136754685	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	136754685	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70266925	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70266925	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	360566000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	98620000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62035000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98888000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	408000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	384000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	298952000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	122000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	514094000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1957000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1190000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5605000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3313000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5043000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	737000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13210000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2040000	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	126000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	102000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	363000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	306000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	7126000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	2029000	USD
	us-gaap	Operating Expenses OperatingExpenses	19178000	USD
	us-gaap	Operating Expenses OperatingExpenses	5659000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	0	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	54000	USD
	us-gaap	Interest Expense InterestExpense	2839000	USD
	us-gaap	Interest Expense InterestExpense	167000	USD
CY2021Q3	orgn	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	0	USD
CY2020Q3	orgn	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	67000	USD
	orgn	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	1426000	USD
	orgn	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	52000	USD
CY2021Q3	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-13481000	USD
CY2020Q3	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	1024000	USD
	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	7363000	USD
	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	1128000	USD
CY2021Q3	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	21511000	USD
CY2020Q3	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	USD
	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	67008000	USD
	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	USD
CY2021Q3	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	27000	USD
CY2020Q3	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	68000	USD
	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	651000	USD
	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	237000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35019000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1077000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	56031000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1110000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	27893000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-3106000	USD
	us-gaap	Net Income Loss NetIncomeLoss	36853000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6769000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1068000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3613000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1010000	USD
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26825000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6719000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36877000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7779000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136749956	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62545275	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89244640	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62544818	shares
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	906000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	287000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62544818	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	26958000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	20299000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27999000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141239965	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62545275	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94029056	shares
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	60000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-3106000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3613000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6769000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1010000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	20299000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	271489000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	636000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	27893000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1068000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	298952000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	122000	USD
	orgn	Reclassification Of Stockholders Convertible Notes Payable ReclassificationOfStockholdersConvertibleNotesPayable	20491000	USD
	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability	54267000	USD
CY2021Q2	orgn	Equity Issuance Costs EquityIssuanceCosts	37000000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	385412000	USD
	orgn	Reclassification Of Equity To Liability Related To Earn Out Provisions Of Business Combination ReclassificationOfEquityToLiabilityRelatedToEarnOutProvisionsOfBusinessCombination	-203082000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	57000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4808000	USD
	us-gaap	Net Income Loss NetIncomeLoss	36853000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	24000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	298952000	USD
	us-gaap	Net Income Loss NetIncomeLoss	36853000	USD
	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	16000	USD
	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	-87000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6769000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	362000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	306000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4808000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	78000	USD
	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	14000	USD
	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	130000	USD
	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	2211000	USD
	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	40000	USD
	orgn	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	1426000	USD
	orgn	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	52000	USD
	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	7363000	USD
	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	1128000	USD
	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	67008000	USD
	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	214000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-954000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3677000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1063000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	501000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-301000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3173000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	196000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	152000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	205000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15616000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3891000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5113000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1404000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5113000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1404000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	11707000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	906000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	0	USD
	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	54267000	USD
	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	1205000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56000	USD
	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1000	USD
	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	467530000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	478674000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2613000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-41000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	457904000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2624000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3612000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	459778000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	988000	USD
	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	20493000	USD
	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	0	USD
	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	203082000	USD
	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	609000	USD
	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	0	USD
	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	81364000	USD
	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	0	USD
	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	2196000	USD
	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	0	USD
	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	0	USD
	orgn	Proceeds For Business Combination ProceedsForBusinessCombination	460000000	USD
	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of the condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock and valuation of convertible preferred stock warrants prior to the Business Combination, valuation of the earnout liability, valuation of assumed common stock warrants liability, carrying amount and useful lives of property and equipment and intangible assets, impairment assessments, stock-based compensation expense, among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and cash equivalents. The Company maintains its cash and cash equivalents accounts with a financial institution where, at times, deposits exceed federal insurance limits. Management believes that the Company is not exposed to significant credit risk as the Company’s deposits are held at financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on these deposits.
CY2019Q4	orgn	Escrow Deposit Fair Value EscrowDepositFairValue	1300000	USD
CY2021Q3	us-gaap	Escrow Deposit EscrowDeposit	300000	USD
CY2020Q4	us-gaap	Escrow Deposit EscrowDeposit	300000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1309000	USD
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	565000	USD
	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	0	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	459288000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	459778000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	USD
	orgn	Grants Received GrantsReceived	100000	USD
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36700000	USD
	orgn	Grants Received GrantsReceived	100000	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	2200000	USD
CY2021Q3	orgn	Percent Of Occurrence Of A Tender Offer Or Exchange Of Our Stockholders PercentOfOccurrenceOfATenderOfferOrExchangeOfOurStockholders	0.50
	orgn	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	2	plan
CY2021Q2	orgn	Business Combination Reversion Recapitalization Conversion Ratio BusinessCombinationReversionRecapitalizationConversionRatio	2.11
CY2021Q2	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	467530000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	100000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	100000	USD
CY2021Q3	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	900000	USD
	orgn	Number Of Vesting Shares NumberOfVestingShares	4500000	shares
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45104000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57321000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	52146000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7370000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7042000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49951000	USD
CY2021Q3	orgn	Change In Fair Value Of Gain Loss Assumed Warrants ChangeInFairValueOfGainLossAssumedWarrants	13500000	USD
CY2020Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	700000	USD
CY2021Q3	orgn	Cumulative Translation Adjustment CumulativeTranslationAdjustment	1200000	USD
CY2020Q4	orgn	Cumulative Translation Adjustment CumulativeTranslationAdjustment	900000	USD
CY2016Q4	orgn	Proceeds From Collaborative Agreement ProceedsFromCollaborativeAgreement	500000	USD
CY2021Q3	us-gaap	Other Income OtherIncome	0	USD
CY2020Q3	us-gaap	Other Income OtherIncome	0	USD
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2016Q4	orgn	Proceeds From Collaborative Agreement ProceedsFromCollaborativeAgreement	500000	USD
CY2018Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1500000	USD
	orgn	Number Of Offtake Supply Agreements NumberOfOfftakeSupplyAgreements	4	agreement
	orgn	Number Of Terminable Offtake Supply Agreements NumberOfTerminableOfftakeSupplyAgreements	2	agreement
CY2021Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	10900000	USD
CY2020Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	10700000	USD
CY2020	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	900000	USD
	orgn	Offtake Agreement Exercise Period OfftakeAgreementExercisePeriod	P1Y
	orgn	Offtake Agreement Purchase Period OfftakeAgreementPurchasePeriod	P10Y
CY2016Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	5000000	USD
	orgn	Earnout Shares Post Triggering Event Period EarnoutSharesPostTriggeringEventPeriod	P10D
CY2021Q3	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2021Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares
CY2019Q2	orgn	Lesser Eligible Costs Percentage LesserEligibleCostsPercentage	0.2214
CY2019Q2	orgn	Lesser Eligible Costs LesserEligibleCosts	23000000	USD
CY2019Q2	orgn	Funding Repayment Period FundingRepaymentPeriod	P15Y
CY2019Q2	orgn	Development Program Liability Funding Reduction Percentage DevelopmentProgramLiabilityFundingReductionPercentage	0.50
CY2019Q2	orgn	Minimum Costs Of Commercial Plants MinimumCostsOfCommercialPlants	500000000	USD
CY2019Q2	orgn	Commercial Plants Constructed And Operational Period CommercialPlantsConstructedAndOperationalPeriod	P30M
CY2021Q3	orgn	Funding Liability FundingLiability	6500000	USD
CY2020Q4	orgn	Funding Liability FundingLiability	6200000	USD
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35476667	shares
CY2021Q3	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	55700000	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.19
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10527368	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10244399	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3808472	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2150941	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	47014274	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7300000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	100000	USD
CY2021Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	100000	USD
CY2021Q3	orgn	Royalty Payment For License Agreement RoyaltyPaymentForLicenseAgreement	0	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	27893000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3106000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	36853000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6769000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	27893000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3106000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	36853000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6769000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136749956	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62545275	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89244640	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4784416	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62544818	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4490009	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141239965	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62545275	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94029056	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62544818	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	4500000	shares
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1615385	shares
CY2021Q3	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	1481531	shares
CY2021Q3	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2021Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares

Files In Submission

Name	View Source	Status
0001802457-21-000008-index-headers.html	Edgar Link	pending
0001802457-21-000008-index.html	Edgar Link	pending
0001802457-21-000008.txt	Edgar Link	pending
0001802457-21-000008-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgn-20210930.htm	Edgar Link	pending
orgn-20210930.xsd	Edgar Link	pending
orgn-20210930xexx311.htm	Edgar Link	pending
orgn-20210930xexx312.htm	Edgar Link	pending
orgn-20210930xexx313.htm	Edgar Link	pending
orgn-20210930xexx321.htm	Edgar Link	pending
orgn-20210930_cal.xml	Edgar Link	unprocessable
orgn-20210930_def.xml	Edgar Link	unprocessable
orgn-20210930_htm.xml	Edgar Link	completed
orgn-20210930_lab.xml	Edgar Link	unprocessable
orgn-20210930_pre.xml	Edgar Link	unprocessable
orgn-2021x0901xexx101.htm	Edgar Link	pending
orgn-2021x0901xexx102.htm	Edgar Link	pending
orgn-2021x0901xexx103.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGN
Origin Materials, Inc. Stock $orgn

2021 Q4 Form 10-Q Financial Statement

#000180245721000008 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGN Origin Materials, Inc. Stock $orgn

2021 Q4 Form 10-Q Financial Statement

#000180245721000008 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGN
Origin Materials, Inc. Stock $orgn